NCT06174623View on ClinicalTrials.gov

Feasibility Study to Support Cardiorenal Function in Acute Decompensated Heart Failure With Diuretic Resistance

NANot yet recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Heart FailureAcute Decompensated Heart FailureCardiorenal SyndromeHeart Failure, CongestiveHeart Failure With Preserved Ejection FractionHeart Failure With Reduced Ejection FractionDiuretic Resistance
Interventions
DEVICE

ModulHeart Support

The ModulHeart device will be implanted in the descending abdominal aorta.

Trial Locations (5)

3168

The Victorian Heart Hospital, Clayton

Unknown

Emergency Cardiology Center by Academician G. Chapidze, Tbilisi

Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi

Tbilisi Heart and Vacular Clinic, Tbilisi

Tbilisi Heart Center, Tbilisi

All Listed Sponsors
lead

Puzzle Medical Devices Inc.

INDUSTRY

NCT06174623 - Feasibility Study to Support Cardiorenal Function in Acute Decompensated Heart Failure With Diuretic Resistance | Biotech Hunter | Biotech Hunter